Related Experiment Videos
Negative halothane-caffeine contracture test in mdx (dystrophin-deficient) mice
V K Patel1, S F Dierdorf, G Krishna
1Department of Pathology, Indiana University Medical Center, Indianapolis.
Metabolism: Clinical and Experimental
|September 1, 1991
Summary
Malignant hyperthermia (MH) susceptibility is not directly caused by dystrophin deficiency, common in Duchenne muscular dystrophy (DMD). Studies in mdx mice show no MH susceptibility, indicating dystrophin
Area of Science:
- Genetics
- Neuromuscular Disorders
- Pharmacology
Background:
- Malignant hyperthermia (MH) genetics are poorly understood.
- Duchenne muscular dystrophy (DMD) is known to be associated with MH.
- Dystrophin deficiency is a characteristic of both DMD and its animal model, the mdx mouse.
Purpose of the Study:
- To investigate the genetic link between Duchenne muscular dystrophy and malignant hyperthermia.
- To determine if dystrophin deficiency plays a direct role in MH susceptibility.
Main Methods:
- Muscle contracture tests were employed to assess MH susceptibility.
- Studies were conducted using the mdx mouse, an animal model for DMD.
Main Results:
- The mdx mouse model for Duchenne muscular dystrophy did not exhibit susceptibility to malignant hyperthermia.
- These findings suggest that dystrophin is not directly involved in the development of MH.
Conclusions:
- Dystrophin deficiency is not a direct cause of malignant hyperthermia.
- The association between DMD and MH may involve other genetic or molecular pathways.